Stories about research and scientific development at Mount Sinai
Delivering the Future of Vaccines With mRNA Technology
One of the great tools that helped turned the tide of the COVID-19 pandemic was the use of vaccines, especially those based on messenger RNA (mRNA) technology. Such vaccines use molecules that teach the cells in the body to generate proteins used by viruses or cancers, allowing the body’s immune system to recognize and fight off future infections.
AI Spotlight: Forecasting ICU Patient States for Improved Outcomes
Artificial intelligence (AI) and machine learning (ML) have seen increasing use in health care, from guiding clinicians in diagnosis to helping them decide the best course of treatment. However, AI still has much unrealized potential in various health care settings.
Yellow III Trial Finds That Lipid Lowering With a PCSK9 Inhibitor Could Benefit Heart Patients on Statin Therapy
Even after high-intensity statin therapy, a considerable residual risk exists for heart attack and stroke among adults with coronary artery disease (CAD). A clinical study led by Mount Sinai offers strong evidence that aggressive lipid lowering with a proprotein...
2023 Jacobi Medallion Award Ceremony
The Mount Sinai Alumni Association and Icahn School of Medicine at Mount Sinai presented accomplished physicians, researchers, educators, and administrators with the 2023 Jacobi Medallion, one of Mount Sinai’s highest awards. The annual ceremony was held Wednesday,...
As the Pandemic Recedes, COVID-19 Research Continues on Many Fronts
While COVID-19 community transmission, mortality, and hospitalization rates have come down across the country in recent months, the efforts to understand more about SARS-CoV-2, the virus responsible for COVID-19, continue at full speed. “The energy is still robust,”...
FREEDOM Trial Finds That High-Dose Anticoagulation Can Improve Survival for Hospitalized COVID-19 Patients
An international trial led by Mount Sinai found that high-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill, when compared to the standard treatment, which is low-dose...
Mount Sinai Experts Discuss the Future of Cancer Care and Research
More than 50 years after the United States formally declared war on cancer, what is the prognosis for innovative cancer research and care? Two Mount Sinai leaders in cancer care and research, Ramon Parsons, MD, PhD, Director of The Tisch Cancer Institute at the Icahn...
Using Insights From the Pandemic to Advance Research on Immunity in Down Syndrome
In April 2020, as the COVID-19 pandemic spread through New York City, Louise Malle, an MD/PhD candidate at the Icahn School of Medicine at Mount Sinai, turned her focus to the disturbing statistics coming out on disease severity. She thought the data might inform her...
Marla C. Dubinsky, MD, Receives 2022 Sherman Prize Recognizing Excellence in Inflammatory Bowel Disease
Marla C. Dubinsky, MD, an internationally recognized leader in pediatric inflammatory bowel disease (IBD), was one of three national recipients of the 2022 Sherman Prize. The award, which recognizes individuals for pioneering achievements that have transformed patient...